The association of anemia with pregnancy is well recognized. In this country the anemia is commonly due to iron deficiencies and is hypochromic. In the tropics a macrocytic, hyperchromic anemia of pregnancy has attracted attention and has been the subject of many recent investigations. Its counterpart in the temperate climates, the macrocytic or so-called pernicious anemia of pregnancy, has been considered a relatively rare dyscrasia.', The macrocytic anemia of pregnancy was first recognized over a century ago when Channing2 reported ten fatal cases. In 1919 Osler7 differentiated the so-called pernicious anemia of pregnancy from typical Addisonian anemia by pointing out that when recovery from the former disease took place it was permanent and the woman might escape it in subsequent pregnancies.
In anisocytosis, the course of the disease, the slow response to liver extract therapy, the lack of neurological signs and symptoms, and the disappearance of the anemia spontaneously on interruption or termination of pregnancy and its failure to return even though liver therapy is stopped.3' 12, 13
The etiology of macrocytic anemia of pregnancy is still unsettled. One explanation is that the primary cause lies in a temporary failure of secretion of the intrinsic factor of Castle by the stomach during the later months of pregnancy.'0 That the secretion of hydrochloric acid may be temporarily impaired in a considerable proportion of pregnant women has been established by Strauss and Castle.9 Other factors held to be of importance are: (a) reduced intake of extrinsic factor consequent on poor diet, capricious appetite, anorexia, and vomiting; (b) impaired absorption from the small intestine due to altered hydrogen-ion concentration of its contents secondary to reduced gastric acidity; and (c) increased demands by the fetus for hematinic principles.
The fact that many cases of this type of anemia do not respond to liver therapy suggests the existence of a state of temporary arrest of erythropoietic function consequent on the absence of some essential factor additional to the liver principle. A similar state of affairs not infrequently occurs in sprue, in which a megaloblastic bone marrow may fail to react to parenteral liver extract, but may respond when the liver extract is supplemented by a high protein diet. This would suggest that some factor in' protein is necessary for erythrocyte productiQn, possibly in connection with stroma formation.3'
The treatment and prognosis in macrocytic anemia of pregnancy during the past century may be divided into several phases. In the first, prior to the use of transfusions and liver extract, the prognosis was very poor, the mortality being 50 to 75 per cent.12 Then, with the addition of liver therapy to the use of transfusions and appropriate management of infections if they exist, the prognosis became good. But Report of a Case Z L., a 34-year-old white nurse, a primigravida, was referred for hematological study by her obstetrician at the beginning of the eighth month of her pregnancy. Her pregnancy was uneventful until the sixth month when her hemoglobin dropped from 80 per cent to 65 per cent. She had been taking multiple vitamins and ferrous sulfate by mouth. She was then placed on an oral liver extract preparation. In spite of this, the hemoglobin fell again to 58 per cent. She then received intensive therapy with parenteral concentrated liver extract during her seventh month. Again, this was to no avail, and her hemoglobin fell to 55 per cent.
Her past history was negative save for a mild anemia that had responded to iron therapy several years prior to her pregnancy.
She now complained of fatigue, loss of appetite, and mental depression. Physical examination, including neurological examination, was negative. A subsequent gastric analysis revealed free hydrochloric acid present in the fasting state. The initial blood count is given in the table. A blood smear revealed the presence of megaloblasts and macrocytosis. The white blood cell count and platelet counts were normal. A diagnosis of macrocytic anemia of pregnancy was made and the patient was started on 15 mg. of folic acid orally daily in addition to her iron and vitamins, which were continued. The subsequent blood counts and blood indices are shown in the table. The patient lived thirty miles away and was not hospitalized till the time of her delivery so that it was not possible to get daily reticulocyte counts. The folic acid was stopped at the time of delivery.
Within a week after starting on the folic acid therapy the patient had lost her mental depression and her fatigue, and had regained her appetite. This sense of well-being continued throughout the remainder of her pregnancy. Her delivery was normal and her infant son was normal. Two and one-half months after delivery and cessation of folic acid therapy her blood count was almost back to normal as shown in the table, and she continued to feel very well.
Comment
The definite hematological response to folic acid in this case did not keep pace with the marked and rapid clinical response. It is possible that a larger daily dose of folic acid might have produced a more rapid rise in the red blood cell count and hemoglobin.
The case reported here furnishes additional evidence as to the state of temporary arrest of maturation of the megaloblast consequent on the absence of some essential factor additional to the liver principle. The response of this patient to the folic acid therapy suggests that the missing factor was supplied by the folic acid. It remains to be seen whether other patients with this type of anemia will all respond to therapy with folic acid.
Summary
The macrocytic or so-called pernicious anemia of pregnancy is described as one in which there is an arrested maturation of the megaloblast. The two features which may be relied upon for certain diagnosis are the appearance of megaloblasts in the peripheral blood and the finding of a megaloblastic change in the bone marrow. The features which distinguish it from true Addisonian pernicious anemia are described. Theories as to the etiology of this anemia are discussed. Many cases respond to treatment with either parenteral or oral liver extract or both. Other cases are refractory to liver extract. A case is reported which was refractory to liver therapy, but responded to folic acid therapy.
